XM does not provide services to residents of the United States of America.

Fortive to spin-off its precision tech segment, CEO to retire post split



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>UPDATE 2-Fortive to spin-off its precision tech segment, CEO to retire post split</title></head><body>

Adds details about leadership changes in paragraph 7-9, updates throughout

Sept 4 (Reuters) -Industrial products maker Fortive FTV.N on Wednesday said it plans to spin off its Precision Technologies segment, creating two independent, publicly traded companies by the fourth quarter of 2025.

The new company, temporarily dubbed "NewCo," will comprise the brands currently operating under Fortive's Precision Technologies segment.

This segment offers electrical testing, measurement, sensing, and material technologies across various vertical end markets, including automotive and medical equipment.

Meanwhile, Fortive will retain its Intelligent Operating Solutions and Advanced Healthcare Solutions business segments.

"With industry-leading margins and cash flow generation, NewCo will be well-positioned to pursue organic growth investments, return cash to shareholders, and seek selective M&A opportunities," the company said.

Shares of the Everett, Washington-based company were up 4.2% in aftermarket trade.

Upon completion of the spin-off, Fortive CEO James Lico will retire and be succeeded by Olumide Soroye, who currently serves as CEO of the company's Intelligent Operation Solutions division.

CFO Chuck E. McLaughlin will retire by the end of the first quarter of 2025.

Tami Newcombe, the current President and CEO of Fortive's Precision Technologies and Advanced Healthcare Solutions business segments, will assume the role of President and CEO of the new company, it said.

Fortive stated it would distribute shares of the new company to its current shareholders based on their existing shareholdings, with no tax implications for them.

The company reaffirmed its Q3 2024 and full-year 2024 financial outlook. It expects its share repurchase program to enhance EPS growth in 2025, with plans to utilize approximately 75% of its available free cash flow for share repurchases.



Reporting by Abhinav Parmar in Bengaluru; Editing by Tasim Zahid

</body></html>

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.